Skip to main content
Caplight Logo









Cernais

Cernais

Private
SienaHealthcare & Life Scienceshttps://www.cernais.com/

Last Round

Grant

Oct 14, 2024

Total Funding Raised

$15,300

Company Overview

Cernais is a life sciences company that has developed an AI-integrated drug discovery platform designed for rare disease treatment.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Subscription SaaS

AI Layer

Application

Keywords

AI drug discoveryRNA therapeuticsrare disease therapeuticsAI biotechcomputational drug discoveryin silico drug discoverydrug discovery platformsmall molecule discoveryRNA modifying moleculesundruggable targetscompound screeningdrug repurposingscreening as a servicepreclinical therapeuticsRett SyndromeCDKL5 Deficiency Disorder

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cernais Comparables

Compare Cernais with similar companies based on industry and business-model similarity.

Cernais comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ReviR Therapeutics
82%
Inceptive
82%
Atomic AI
82%

Cernais Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 14, 2024
AcceleratorOct 14, 2024

Cernais Investors

Notable investors and investment history

Cernais investors
InvestorRounds
Regione ToscanaGrant, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 14, 2024

    $10K round from Regione Toscana

  • Oct 14, 2024

    $5.3K grant from Regione Toscana

Cernais Filings

Explore SEC and related filing metadata, where available.

Cernais filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cernais's valuation, stock price, and market status.

Is Cernais a public or private company?

Cernais is a private company.

What is the current stock price of Cernais?

Cernais is a private company with no public stock price. No recent secondary market data is available.

How much is Cernais worth (valuation)?

Valuation information for Cernais is not publicly available.

Can I buy Cernais stock?

Cernais shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cernais's last funding round?

Cernais's most recent funding round was Grant on October 14, 2024.

Who are the main investors in Cernais?

Key investors in Cernais include Regione Toscana.

Will Cernais IPO soon?

No public IPO plans have been announced for Cernais.

How can I track Cernais secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cernais's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSiena
Year Founded2024
Last FundingOct 14, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?